Multiple endocrine neoplasia type 1: Difference between revisions
Irfan Dotani (talk | contribs) No edit summary |
(Mahshid) |
||
| (2 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Multiple endocrine neoplasia type 1}} | {{Multiple endocrine neoplasia type 1}} | ||
{{CMG}}; {{AE}} {{Ammu}} | {{CMG}}; {{AE}} {{Ammu}} {{Ajay}} {{ARK}} | ||
'''For patient information, click [[{{PAGENAME}} (patient information)|here]].''' | '''For patient information, click [[{{PAGENAME}} (patient information)|here]].''' | ||
| Line 32: | Line 32: | ||
==Treatment== | ==Treatment== | ||
[[Multiple endocrine neoplasia type 1 medical therapy|Medical Therapy]] | [[Multiple endocrine neoplasia type 1 surgery|Surgery]] | [[Multiple endocrine neoplasia type 1 primary prevention|Primary Prevention]] | [[Multiple endocrine neoplasia type 1 secondary prevention|Secondary Prevention]] | [[Multiple endocrine neoplasia type 1 cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Multiple endocrine neoplasia type 1 future or investigational therapies|Future or Investigational Therapies]] | [[Multiple endocrine neoplasia type 1 medical therapy|Medical Therapy]] | [[Multiple endocrine neoplasia type 1 surgery|Surgery]] | [[Multiple endocrine neoplasia type 1 primary prevention|Primary Prevention]] | [[Multiple endocrine neoplasia type 1 secondary prevention|Secondary Prevention]] | [[Multiple endocrine neoplasia type 1 cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Multiple endocrine neoplasia type 1 future or investigational therapies|Future or Investigational Therapies]] | ||
==Case Studies== | |||
[[Multiple endocrine neoplasia type 1 case study one|Case #1]] | |||
[[Category:Oncology]] | [[Category:Oncology]] | ||
[[Category: Endocrinology]] | [[Category: Endocrinology]] | ||
[[Category:Up-To-Date]] | |||
[[Category:Oncology]] | |||
[[Category:Medicine]] | |||
[[Category:Endocrinology]] | |||
[[Category:Surgery]] | |||
Latest revision as of 02:44, 27 November 2017
|
Multiple endocrine neoplasia type 1 Microchapters |
|
Differentiating Multiple endocrine neoplasia type 1 from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Multiple endocrine neoplasia type 1 On the Web |
|
American Roentgen Ray Society Images of Multiple endocrine neoplasia type 1 |
|
Directions to Hospitals Treating Multiple endocrine neoplasia type 1 |
|
Risk calculators and risk factors for Multiple endocrine neoplasia type 1 |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ammu Susheela, M.D. [2] Ajay Gade MD[3]] Aravind Reddy Kothagadi M.B.B.S[4]
For patient information, click here.
Synonyms and keywords: Multiple endocrine adenomatosis, type 1; Multiple endocrine neoplasia syndrome type 1; Wermer syndrome; MEN, type 1; MEN 1 syndrome; MEN 1 - Multiple endocrine neoplasia syndrome type 1; MEN type I; Multiple endocrine neoplasia type 1
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Multiple Endocrine Neoplasia Type 1 From Other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | Electrocardiogram | X Ray | CT | MRI | Ultrasound | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies